Cargando…
A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy
Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-ind...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823383/ https://www.ncbi.nlm.nih.gov/pubmed/36615627 http://dx.doi.org/10.3390/molecules28010423 |
_version_ | 1784866146037530624 |
---|---|
author | Ran, Ruixue Guo, Sinan Jiang, Xiaoyu Qian, Zhanyin Guo, Zhaoyang Wang, Yinsong Cao, Mingxin Yang, Xiaoying |
author_facet | Ran, Ruixue Guo, Sinan Jiang, Xiaoyu Qian, Zhanyin Guo, Zhaoyang Wang, Yinsong Cao, Mingxin Yang, Xiaoying |
author_sort | Ran, Ruixue |
collection | PubMed |
description | Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu(2−x)Se nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu(2−x)Se nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu(2−x)Se/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies. |
format | Online Article Text |
id | pubmed-9823383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98233832023-01-08 A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy Ran, Ruixue Guo, Sinan Jiang, Xiaoyu Qian, Zhanyin Guo, Zhaoyang Wang, Yinsong Cao, Mingxin Yang, Xiaoying Molecules Article Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu(2−x)Se nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu(2−x)Se nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu(2−x)Se/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies. MDPI 2023-01-03 /pmc/articles/PMC9823383/ /pubmed/36615627 http://dx.doi.org/10.3390/molecules28010423 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ran, Ruixue Guo, Sinan Jiang, Xiaoyu Qian, Zhanyin Guo, Zhaoyang Wang, Yinsong Cao, Mingxin Yang, Xiaoying A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title | A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title_full | A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title_fullStr | A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title_full_unstemmed | A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title_short | A Cell-Penetrating Peptide Modified Cu(2−x)Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy |
title_sort | cell-penetrating peptide modified cu(2−x)se/au nanohybrid with enhanced efficacy for combined radio-photothermal therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823383/ https://www.ncbi.nlm.nih.gov/pubmed/36615627 http://dx.doi.org/10.3390/molecules28010423 |
work_keys_str_mv | AT ranruixue acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT guosinan acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT jiangxiaoyu acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT qianzhanyin acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT guozhaoyang acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT wangyinsong acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT caomingxin acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT yangxiaoying acellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT ranruixue cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT guosinan cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT jiangxiaoyu cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT qianzhanyin cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT guozhaoyang cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT wangyinsong cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT caomingxin cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy AT yangxiaoying cellpenetratingpeptidemodifiedcu2xseaunanohybridwithenhancedefficacyforcombinedradiophotothermaltherapy |